Document is current
Any future updates will be listed below
-
Authors
Quardokus, Ellen M. https://orcid.org/0000-0001-7655-4833
Saunders, Diane C. https://orcid.org/0000-0002-8849-6746
McDonough, Elizabeth https://orcid.org/0000-0001-7524-8260
Hickey, John W. https://orcid.org/0000-0001-9961-7673
Werlein, Christopher https://orcid.org/0000-0002-7694-4257
Surrette, Christine
Rajbhandari, Presha
Casals, Anna Martinez
Tian, Hua https://orcid.org/0000-0002-3598-0219
Lowery, Lisa
Neumann, Elizabeth K.
Björklund, Frida
Neelakantan, Taruna V.
Croteau, Josh https://orcid.org/0000-0002-8142-0482
Wiblin, Anne E. https://orcid.org/0000-0002-6087-5701
Fisher, Jeremy https://orcid.org/0000-0002-7296-586X
Livengood, April J.
Dowell, Karen G.
Silverstein, Jonathan C. https://orcid.org/0000-0002-9252-6039
Spraggins, Jeffrey M. https://orcid.org/0000-0001-9198-5498
Pryhuber, Gloria S. https://orcid.org/0000-0002-9185-3994
Deutsch, Gail
Ginty, Fiona
Nolan, Garry P.
Melov, Simon https://orcid.org/0000-0001-8554-2834
Jonigk, Danny https://orcid.org/0000-0002-5251-2281
Caldwell, Michael A.
Vlachos, Ioannis S. https://orcid.org/0000-0002-8849-808X
Muller, Werner https://orcid.org/0000-0002-1297-9725
Gehlenborg, Nils https://orcid.org/0000-0003-0327-8297
Stockwell, Brent R. https://orcid.org/0000-0002-3532-3868
Lundberg, Emma https://orcid.org/0000-0001-7034-0850
Snyder, Michael P. https://orcid.org/0000-0003-0784-7987
Germain, Ronald N. https://orcid.org/0000-0003-1495-9143
Camarillo, Jeannie M.
Kelleher, Neil L. https://orcid.org/0000-0002-8815-3372
Börner, Katy https://orcid.org/0000-0002-3321-6137
Radtke, Andrea J. https://orcid.org/0000-0003-4379-8967
- License Information
-
More Information
Article History
Received: 12 July 2022
Accepted: 14 March 2023
First Online: 19 July 2023
Competing interests
: A.E.W. is an employee and shareholder of Abcam PLC. J.F. is an employee of Cell Signaling Technology, Inc. J.C. is an employee and stakeholder of BioLegend. A.J.L. is an employee and shareholder of Thermo Fisher Scientific. E.M., L.L., C.S. and F.G. are employees of GE Research. B.R.S. is an inventor on patents and patent applications involving small molecule drug discovery, and the 3F3-FMA antibody, cofounded and serves as a consultant to Exarta Therapeutics and ProJenX Inc.; holds equity in Sonata Therapeutics, receives sponsored research from Sumitomo Pharma Oncology Inc and serves as a consultant to Weatherwax Biotechnologies Corporation and Akin Gump Strauss Hauer and Feld LLP. M.P.S. is cofounder and advisory board member of Personalis, Qbio, January AI, Mirvie, Filtricine, Fodsel, Lollo and Protos. G.P.N. has equity in and is a scientific advisory board member of Akoya Biosciences, Inc. I.S.V. consults for Guidepoint Global, Cowen, Mosaic and NextRNA. N.G. is a cofounder and equity owner of Datavisyn. W.M. is an employee of Miltenyi Biotec B.V. and Co. KG. E.L. serves as a consultant for 10x Genomics, Moleculent AB, Pixelgen Technologies and Nautilus Biotechnology. K.G.D. is an employee of Akoya Biosciences. The remaining authors declare no competing interests.
